Centiva Capital, LP Heron Therapeutics, Inc. Transaction History

Centiva Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.25 - $4.67 $37,998 - $78,866	16,888 Added 120.63%	30,888 $77,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $37,240 - $75,180	14,000 New	14,000 $59,000
Q3 2021 Nov 15, 2021	SELL	$10.13 - $15.0 $175,208 - $259,440	-17,296 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $229,517 - $319,630	17,296 New	17,296 $268,000

176

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $194M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.